Literature DB >> 9688850

Hypotonicity activates a lanthanide-sensitive pathway for K+ release in A6 epithelia.

P De Smet1, J Li, W Van Driessche.   

Abstract

The nature of the pathway for K+ release activated during regulatory volume decrease (RVD) in A6 epithelia was investigated by measuring cell thickness (Tc) as an index of cell volume and by probing K+ efflux with 86Rb as tracer for K+ (RRb). Cell swelling was induced by sudden reduction of basolateral osmolality (from 260 to 140 mosmol/kgH2O). Experiments were performed in the absence of Na+ transport. Apical RRb was negligible in iso- and hyposmotic conditions. On the other hand, osmotic shock increased basolateral RRb (RblRb) rapidly, reaching a maximum 7 min after the peak in Tc. Quinine (0.5 mM) completely inhibited RVD and RblRb. Also verapamil (0.2 mM) impeded volume recovery considerably; lidocaine (0.2 mM) did not exert a noticeable effect. The K+ channel blocker Ba2+ (30 mM) delayed RVD but could not prevent complete volume recovery. Cs+ inhibited RVD noticeably at concentrations <40 mM. With large Cs+ concentrations (>40 mM), the initial osmometric swelling was followed by a gradual increase of Tc, suggesting activation of Cs+ influx. Chronic exposure of the basolateral surface to 0.5 mM La3+ or Gd3+ completely abolished RVD and RblRb. Acute administration of lanthanides at the time of osmolality decrease did not affect the initial phase of RVD and reduced RblRb only slightly. Apical Gd3+ exerted an inhibitory effect on RVD and RblRb. The effect of Gd3+ should therefore be localized at an intracellular site. The role of Ca2+ entry could be excluded by failure of extracellular Ca2+ removal to inhibit volume recovery. In contrast to lanthanides, chronically and acutely administered Mg2+ (0.5 mM) inhibited RVD and RblRb by approximately 50%. These data suggest that K+ excretion during RVD occurs through a rather poorly selective pathway that does not seem to be directly activated by membrane stretch.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688850     DOI: 10.1152/ajpcell.1998.275.1.C189

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Lack of threshold for anisotonic cell volume regulation.

Authors:  Kunyan Kuang; Maimiti Yiming; Zhaorong Zhu; Pavel Iserovich; Friedrich P Diecke; Jorge Fischbarg
Journal:  J Membr Biol       Date:  2006-09-18       Impact factor: 1.843

2.  Mechanosensitivity of wild-type and G551D cystic fibrosis transmembrane conductance regulator (CFTR) controls regulatory volume decrease in simple epithelia.

Authors:  Changyan Xie; Xu Cao; Xibing Chen; Dong Wang; Wei Kevin Zhang; Ying Sun; Wenbao Hu; Zijing Zhou; Yan Wang; Pingbo Huang
Journal:  FASEB J       Date:  2015-12-18       Impact factor: 5.191

3.  Regulation of WNK1 kinase by extracellular potassium.

Authors:  Shotaro Naito; Akihito Ohta; Eisei Sohara; Eriko Ohta; Tatemitsu Rai; Sei Sasaki; Shinichi Uchida
Journal:  Clin Exp Nephrol       Date:  2010-11-25       Impact factor: 2.801

4.  Hypotonic cell swelling stimulates permeability to cAMP in a rat colonic cell line.

Authors:  P E Golstein; A Daifi; R Crutzen; A Boom; W Van Driessche; R Beauwens
Journal:  Pflugers Arch       Date:  2004-01-16       Impact factor: 3.657

5.  Recovery of cell volume and electrolytes of A6 cells after re-establishing isotonicity following hypotonic stress.

Authors:  T Grosse; I Heid; I Oztürk; S Borgmann; F X Beck; A Dörge
Journal:  Pflugers Arch       Date:  2003-07-26       Impact factor: 3.657

6.  Pharmacological comparison of swelling-activated excitatory amino acid release and Cl- currents in cultured rat astrocytes.

Authors:  Iskandar F Abdullaev; Alena Rudkouskaya; Gary P Schools; Harold K Kimelberg; Alexander A Mongin
Journal:  J Physiol       Date:  2006-05-01       Impact factor: 5.182

7.  Suppression of cell membrane permeability by suramin: involvement of its inhibitory actions on connexin 43 hemichannels.

Authors:  Yuan Chi; Kun Gao; Hui Zhang; Masayuki Takeda; Jian Yao
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.